UXJA Short Volume

First Trust Exchange-Traded Fund VIII - FT Vest U.S. Equity Uncapped Accelerator ETF - January (UXJA) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $11.7M, listed on CBOE, carrying a beta of 1.09 to the broader market. UXJA starts with a 2% negative return, plus the expense ratio, each year in January. public since 2025-01-21.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-10-15
Short Volume
202
Total Volume
332
Short %
60.84%
30-Day Avg Short %
52.10%

Showing 30 days of FINRA short volume data for First Trust Exchange-Traded Fund VIII - FT Vest U.S. Equity Uncapped Accelerator ETF - January.

Learn how short volume is reported and how to read the data →

Frequently asked UXJA short volume questions

What is the daily UXJA short volume?
As of Oct 15, 2026, First Trust Exchange-Traded Fund VIII - FT Vest U.S. Equity Uncapped Accelerator ETF - January (UXJA) short volume is 202 shares against 332 total reported volume, or 60.84% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is UXJA short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does UXJA short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.